Dec 7, 2025
Have there been serious adverse events or deaths linked to Memoblast in clinical trials or postmarketing reports?
Available reports about Mesoblast’s lead MSC products (remestemcel‑L / Ryoncil and rexlemestrocel‑L / Revascor) document serious adverse reactions in trials—most commonly infections, fever, hemorrhage...